InsiderTrades

Form 4 for PCVX Vaxcyte, Inc.

Accepted 2024-07-24 00:00:00 ET · period of report 2024-07-23 · accession 0001649094-24-000039 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-07-24 2024-07-23 PCVX PICKERING GRANT CEO, Dir S - Sale+OE $84.26 -15.0K 488.2K -3% -$1.26M
D 2024-07-24 2024-07-23 PCVX PICKERING GRANT CEO, Dir M - OptEx $2.03 +15.0K 493.9K +3% +$30.4K
D 2024-07-24 2024-07-23 PCVX PICKERING GRANT CEO, Dir M - OptEx $0.00 -15.0K 182.3K -8% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-07-23 S D 9,282 $84.53 478,888 D — — (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $84.175 to $84.98. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
2 Common Common Stock 2024-07-23 M A 15,000 $2.03 493,888 D — —
3 Common Common Stock 2024-07-23 S D 5,718 $83.83 488,170 D — — (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $83.17 to $84.145. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
4 Derivative Stock Option (right to buy) 2024-07-23 M D 15,000 $0.00 182,327 D $2.03 · — to 2028-07-23 15,000 Common Stock (F6) Stock Option is fully vested and exercisable.